Capivasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer: The PAKT trial

  1. Schmid, P.
  2. Abraham, J.
  3. Chan, S.
  4. Wheatley, D.
  5. Brunt, A.M.
  6. Nemsadze, G.
  7. Baird, R.D.
  8. Park, Y.H.
  9. Hall, P.S.
  10. Perren, T.
  11. Stein, R.C.
  12. Mangel, L.
  13. Ferrero, J.-M.
  14. Phillips, M.
  15. Conibear, J.
  16. Cortes, J.
  17. Foxley, A.
  18. de Bruin, E.C.
  19. McEwen, R.
  20. Stetson, D.
  21. Dougherty, B.
  22. Sarker, S.-J.
  23. Prendergast, A.
  24. McLaughlin-Callan, M.
  25. Burgess, M.
  26. Lawrence, C.
  27. Cartwright, H.
  28. Mousa, K.
  29. Turner, N.C.
  30. Erakutsi egile guztiak +
Aldizkaria:
Journal of Clinical Oncology

ISSN: 1527-7755,  0732-183X

Argitalpen urtea: 2020

Alea: 38

Zenbakia: 5

Orrialdeak: 423-433

Mota: Biltzar ekarpena

DOI: 10.1200/JCO.19.00368 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus